EdgarLookup

ORAMED PHARMACEUTICALS INC. — 8-K Filings

261 8-K filings on record

This page lists all 8-K filings submitted to the SEC by ORAMED PHARMACEUTICALS INC. (ORMP), sorted by most recent first. Each row links to the full filing on EdgarLookup. ORAMED PHARMACEUTICALS INC. has filed 261 8-K documents with the SEC since 2002. To view all SEC filings by ORAMED PHARMACEUTICALS INC., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 10-Q/A 10-QT 10KSB 10KSB/A 10QSB 10QSB/A 3 3/A 4 4/A 424B3 424B5 424B7 5 8-A12B 8-A12G 8-K 8-K/A ARS CERTNAS CORRESP CT ORDER D D/A DEF 14A EFFECT FWP NT 10-K NT 10-Q NTN 10Q POS AM PRE 14A PRER14A REGDEX RW S-1 S-1/A S-3 S-3MEF S-8 SB-2 SB-2/A SC 13D SC 13D/A SC 13G SC 13G/A SC 14F1 SCHEDULE 13D SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
8-K 8-K 0001012975-26-000195 Feb 20, 2026 Feb 19, 2026
8-K CURRENT REPORT 0001213900-26-004382 Jan 14, 2026 Jan 12, 2026
8-K CURRENT REPORT 0001213900-26-001983 Jan 7, 2026
8-K CURRENT REPORT 0001213900-25-127133 Dec 31, 2025
8-K 8-K 0001012975-25-000992 Dec 31, 2025 Dec 30, 2025
8-K CURRENT REPORT 0001213900-25-111310 Nov 17, 2025
8-K CURRENT REPORT 0001213900-25-111298 Nov 17, 2025 Nov 16, 2025
8-K CURRENT REPORT 0001213900-25-101825 Oct 24, 2025 Oct 20, 2025
8-K CURRENT REPORT 0001213900-25-096322 Oct 6, 2025 Sep 30, 2025
8-K CURRENT REPORT 0001213900-25-079361 Aug 21, 2025 Aug 19, 2025
8-K CURRENT REPORT 0001213900-25-066819 Jul 23, 2025 Jul 22, 2025
8-K CURRENT REPORT 0001213900-25-046436 May 21, 2025
8-K CURRENT REPORT 0001213900-25-036109 Apr 28, 2025 Apr 24, 2025
8-K CURRENT REPORT 0001213900-25-019437 Mar 3, 2025 Feb 28, 2025
8-K CURRENT REPORT 0001213900-25-018135 Feb 27, 2025 Feb 22, 2025
8-K CURRENT REPORT 0001213900-25-012244 Feb 11, 2025 Feb 7, 2025
8-K CURRENT REPORT 0001213900-25-005212 Jan 22, 2025 Jan 21, 2025
8-K CURRENT REPORT 0001213900-25-000517 Jan 3, 2025 Jan 2, 2025
8-K CURRENT REPORT 0001213900-24-109825 Dec 17, 2024 Dec 13, 2024
8-K CURRENT REPORT 0001213900-24-091795 Oct 29, 2024 Oct 24, 2024
8-K CURRENT REPORT 0001213900-24-086214 Oct 8, 2024 Oct 7, 2024
8-K CURRENT REPORT 0001213900-24-082237 Sep 26, 2024 Sep 23, 2024
8-K CURRENT REPORT 0001213900-24-080812 Sep 23, 2024 Sep 20, 2024
8-K CURRENT REPORT 0001213900-24-064732 Aug 2, 2024 Aug 1, 2024
8-K CURRENT REPORT 0001213900-24-055950 Jun 26, 2024
8-K CURRENT REPORT 0001213900-24-055006 Jun 24, 2024 Jun 20, 2024
8-K CURRENT REPORT 0001213900-24-051355 Jun 10, 2024 Jun 6, 2024
8-K CURRENT REPORT 0001213900-24-041847 May 13, 2024 May 10, 2024
8-K CURRENT REPORT 0001213900-24-039909 May 6, 2024 May 2, 2024
8-K CURRENT REPORT 0001213900-24-023721 Mar 19, 2024 Mar 14, 2024
8-K CURRENT REPORT 0001213900-24-023571 Mar 18, 2024
8-K CURRENT REPORT 0001213900-24-023584 Mar 18, 2024 Mar 12, 2024
8-K CURRENT REPORT 0001213900-24-015108 Feb 20, 2024
8-K CURRENT REPORT 0001213900-24-005780 Jan 23, 2024 Jan 22, 2024
8-K CURRENT REPORT 0001213900-24-004905 Jan 19, 2024 Jan 17, 2024
8-K CURRENT REPORT 0001213900-23-097505 Dec 21, 2023
8-K CURRENT REPORT 0001213900-23-096536 Dec 18, 2023
8-K CURRENT REPORT 0001213900-23-079586 Sep 26, 2023 Sep 21, 2023
8-K CURRENT REPORT 0001213900-23-076238 Sep 13, 2023 Sep 11, 2023
8-K CURRENT REPORT DATED AUGUST 17, 2023 0001213900-23-069538 Aug 22, 2023 Aug 17, 2023
8-K CURRENT REPORT 0001213900-23-064786 Aug 9, 2023 Aug 7, 2023
8-K CURRENT REPORT 0001213900-23-063876 Aug 7, 2023 Aug 4, 2023
8-K CURRENT REPORT 0001213900-23-056806 Jul 13, 2023
8-K CURRENT REPORT 0001213900-23-034728 May 1, 2023
8-K CURRENT REPORT 0001213900-23-014884 Feb 27, 2023 Feb 23, 2023
8-K CURRENT REPORT 0001213900-23-002343 Jan 12, 2023 Jan 11, 2023
8-K CURRENT REPORT 0001213900-22-078902 Dec 12, 2022
8-K CURRENT REPORT 0001213900-22-071607 Nov 14, 2022 Nov 13, 2022
8-K CURRENT REPORT 0001213900-22-071230 Nov 10, 2022
8-K CURRENT REPORT 0001213900-22-057036 Sep 19, 2022 Sep 15, 2022